Drawing for NANOPASS

USPTO serial 99537632

NANOPASS

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
SHOOR, AMIT KUMAR
Law office
TMO LAW OFFICE 117

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with NANOPASS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Danielle K. Muñoz

Danielle K. Muñoz Fitch, Even, Tabin & Flannery LLP120 South LaSalle StreetSuite 2100Chicago, IL 60603

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus and instruments, namely, needles for injection of pharmaceutical preparations and vaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 22, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 22, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 22, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 20, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 12, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 20, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2026DOCKASSIGNED TO EXAMINER—
Feb 12, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 29, 2025TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Dec 29, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 9, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 9, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance